Literature DB >> 35367315

What happens when the mitochondrial H+-translocating F1FO-ATP(hydrol)ase becomes a molecular target of calcium? The pore opens.

Salvatore Nesci1.   

Abstract

The F1FO-ATPase has Mg2+ cofactor as the natural divalent cation to support the bifunctional activity of ATP synthesis and hydrolysis. Different physio(patho)logical conditions permit the molecular interaction of Ca2+ with the enzyme and the modification of the biological role. Three distinct binding regions of Ca2+ have been localized on the enzyme complex: one in the F1 catalytic sites and the other two sites in the membrane-embedded domain FO. In all likelihood, Ca2+-activated enzyme most frequently works as an H+-translocating F1FO-ATP(hydrol)ase with a monofunctional activity that triggers the formation of mitochondrial permeability transition pore (mPTP) phenomenon. The protein(s) component of the mPTP is considered an arcane mystery. However, the F1FO-ATPase could reveal the molecular mechanism of pore opening when Ca2+ is bound to the enzyme. In this regard, the role of Ca2+-dependent function of the F1FO-ATPase in the formation of the mPTP is discussed.
Copyright © 2022 Elsevier B.V. and Société Française de Biochimie et Biologie Moléculaire (SFBBM). All rights reserved.

Entities:  

Keywords:  Calcium; Divalent cations; F(1)F(O)-ATPase; Mitochondria; Permeability transition pore

Mesh:

Substances:

Year:  2022        PMID: 35367315     DOI: 10.1016/j.biochi.2022.03.012

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  1 in total

1.  The Impairment of Cell Metabolism by Cardiovascular Toxicity of Doxorubicin Is Reversed by Bergamot Polyphenolic Fraction Treatment in Endothelial Cells.

Authors:  Cristina Algieri; Chiara Bernardini; Francesca Oppedisano; Debora La Mantia; Fabiana Trombetti; Ernesto Palma; Monica Forni; Vincenzo Mollace; Giovanni Romeo; Ilaria Troisio; Salvatore Nesci
Journal:  Int J Mol Sci       Date:  2022-08-11       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.